Updating magnetic resonance imaging of small bowel: Imaging protocols and clinical indications

World Journal of Gastroenterology

Volumn 14, Issue 21, 2008, Pages 3403-3409

  Zhu, Jiong ^a   Xu, Jian Rong ^a   Gong, Hong Xia ^a   Zhou, Yan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Crohn's; Magnetic resonance imaging; Neoplasm; Small bowel

Indexed keywords

BARIUM SULFATE; CONTRAST MEDIUM; ENEMA; GADOLINIUM CHELATE; IRON OXIDE; MACROGOL; MANGANESE; MANNITOL; PERFLUOROOCTYL BROMIDE; SORBITOL; WATER;

ABDOMINAL CRAMP; ADENOCARCINOMA; BENIGN TUMOR; CANCER CLASSIFICATION; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIARRHEA; DISEASE ACTIVITY; ENTERITIS; FLUOROSCOPY; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HYPEROSMOLALITY; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INCIDENTAL FINDING; INTERMETHOD COMPARISON; INTESTINE DISTENSION; INTESTINE MOTILITY; INTESTINE POLYP; LIVER METASTASIS; MALIGNANT NEOPLASTIC DISEASE; METEORISM; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIATION EXPOSURE; REACTION TIME; REVIEW; SMALL INTESTINE DISEASE; SMALL INTESTINE TUMOR; TUMOR LOCALIZATION;

EID: 54349118939     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3403     Document Type: Review

References (54)

1. Ernst O, Asselah T, Cablan X, Sergent G. Breath-hold fast spin-echo MR imaging of Crohn's disease. AJR Am J Roentgenol 1998; 170: 127-128
2. Rieber A, Wruk D, Nussle K, Aschoff AJ, Reinshagen M, Adler G, Brambs HJ, Tomczak R. [MRI of the abdomen combined with enteroclysis in Crohn disease using oral and intravenous Gd-DTPA] Radiologe 1998; 38: 23-28
3. Holzknecht N, Helmberger T, von Ritter C, Gauger J, Faber S, Reiser M. [MRI of the small intestine with rapid MRI sequences in Crohn disease after enteroclysis with oral iron particles] Radiologe 1998; 38: 29-36
4. Ha HK, Lee EH, Lim CH. Shin YM, Jeong YK, Yoon KH, Lee MG, Min YI, Auh YH. Application of MRI for small intestinal diseases. J Magn Reson Imaging 1998; 8: 375-383
5. Lee JK, Marcos HB, Semelka RC. MR imaging of the small bowel using the HASTE sequence. AJR Am J Roentgenol 1998; 170:1457-1463
6. Regan F, Beall DP, Bohlman ME, Khazan R, Sufi A, Schaefer DC. Fast MR imaging and the detection of small-bowel obstruction. AJR Am J Roentgenol 1998, 170: 1465-1469
7. Adamek HE, Breer H, Karschkes T, Albert J, Riemann JF. Magnetic resonance imaging in gastroenterology: time to say good-bye to all that endoscopy? Endoscopy 2000; 32: 406-410
8. Wong SH, Wong VW, Sung JJ. Virtual colonoscopy-induced perforation in a patient with Crohn's disease. World J Gastroenterol 2007; 13: 978-979
9. Saibeni S, Rondonotti E, Iozzelli A, Spina L, Tontini GE, Cavallaro F, Ciscato C, de Franchis R, Sardanelli F, Vecchi M. Imaging of the small bowel in Crohn's disease: a review of old and new techniques. World J Gastroenterol 2007; 13: 3279-3287
10. Chou CK, Liu GC, Chen LT, Jaw TS. The use of MRI in bowel obstruction. Abdom Imaging 1993, 18: 131-135
11. Beall DP, Fortman BJ, Lawler BC, Regan F. Imaging bowel obstruction: a comparison between fast magnetic resonance imaging and hilical computed tomography. Clin Radiol 2002; 57: 719-724
12. Hirohashi S, Uchida H, Yoshikawa K, Fujita N, Ohtomo K, Ynasa Y, Kawamura Y, Matsui O. Large scale clinical evaluation of bowel contrast agent containing ferric ammonium citrate in MRI. Magn Reson Imaging 1994; 12: 837-846
13. Rieber A, Nussle K, Reinshagen M, Brambs HJ, Gabelmann A. MRI of the abdomen with positive oral contrast agents for the diagnosis of inflammatory small bowel disease. Abdom Imaging 2002; 27: 394-399
14. Vlahos L, Gouliamos A, Athanasopoulou A, Kotoulas G, Claus W, Hatziioannou A, Kalovidouris A, Papavasiliou C. A comparative study between Gd-DTPA and oral magnetic particles (OMP) as gastrointestinal (GI) contrast agents for MRI of the abdomen. Magn Reson Imaging 1994; 12: 719-726
15. Rieber A, Aschoff A, Nussle K, Wruk D, Tomczak R, Reinshagen M, Adler G, Byanibs HJ. MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis. Eur Radiol 2000; 10: 1377-1382
16. Hiraishi K, Narabayashi I, Fujita O, Yamamoto K, Sagami A, Hisada Y, Saika Y, Adachi I, Hasegawa H. Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology 1995; 194: 119-123
17. Brown JJ, Duncan JR, Heiken JP, Balfe DM, Corr AP, Mirowitz SA, Eilenberg SS, Lee JK. Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: use with and without glucagon. Radiology 1991; 181: 455-460
18. Johnson WK, Stoupis C, Torres GM, Rosenberg EB, Ros PR. Superparamagnetic iron oxide (SPIO) as an oral contrast agent in gastrointestinal (GI) magnetic resonance imaging (MRI): comparison with state-of-the-art computed tomography (CT). Magn Reson Imaging 1996; 14: 43-49
19. Ajaj W, Goyen M, Schneemann H, Kuehle C, Nuefer M, Ruehm SG, Goehde SC, Lauenstein TC. Oral contrast agents for small bowel distension in MRI: influence of the osmolarity for small bowel distention. Eur Radiol 2005; 15: 140-1406
20. Maglinte DD, Siegelman ES, Kelvin FM. MR enteroclysis: the future of small-bowel imaging? Radiology 2000; 215: 639-641
21. Lomas DJ, Graves MJ. Small bowel MRI using water as a contrast medium. Br J Radiol 1999; 72: 994-997
22. Grubnic S, Padhani AR, Revell PB, Husband JE. Comparative efficacy of and sequence choice for two oral contrast agents used during MR imaging. AJR Am J Roentgenol 1999; 173: 173-178
23. Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC. Dose optimization of mannitol solution for small bowel distension in MRI. J Magn Reson Imaging 20044; 20: 648-653
24. Kuehle CA, Ajaj W, Ladd SC, Massing S, Barkhausen J, Lauenstein TC. Hydro-MRI of the small bowel: effect of contrast volume, timing of contrast administration, and data acquisition on bowel distention. AJR Am J Roentgenol 2006; 187: W375-W385
25. Lauenstein TC, Schneermann H, Vogt FM, Herborn CU, Ruhm SG, Debatin JF. Optimization of oral contrast agents for MR imaging of the small bowel. Radiology 2003; 228: 279-283
26. Ajaj W, Goehde SC, Schneemann H, Ruehm SG, Debatin JF, Lauenstein TC. Oral contrast agents for small bowel MRI: comparison of different additives to optimize bowel distension. Eur Radiol 2004; 14: 458-464
27. McKenna DA, Roche CJ, Murphy JM, McCarthy PA. Polyethylene glycol solution as an oral contrast agent for MRI of the small bowel in a patient population. Clin Radiol 2006; 61: 966-970
28. Umschaden HW, Szolar D, Gasser J, Umschaden M, Haselbach H. Small-bowel disease: comparison of MR enteroclysis images with conventional enteroclysis and surgical findings. Radiology 2000; 215: 717-725
29. Wiarda BM, Kuipers EJ, Heitbrink MA, van Oijen A, Stoker J. MR Enteroclysis of inflammatory small-Abowel diseases. AJR Am J Roentgenol 2006; 187: 522-531
30. Low RN, Sebrechts CP, Politoske DA, Bennett MT, Flores S, Snyder RJ, Pressman JH. Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium-enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 2002; 222: 652-660
31. Albert JG, Martiny F, Krummenerl A, Stock K, Lesske J, Gobel CM, Lotterer E, Nietsch HH, Behrmann C, Fleig WE. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis. Gut 2005; 54: 1721-1727
32. Prassopoulos P, Papanikolaou N, Grammatikakis J, Rousomoustakaki M, Maris T, Gourtsoyiannis N. MR enteroclysis iniaging of Crohn disease. Radiolographics 2001; 21 Spec No: S161-S172
33. Furukawa A, Saotome T, Yamasaki M, Maeda K, Nitta N, Takahashi M, Tsujikawa T, Fujiyania Y, Murata K, Sakamoto T. Cross-sectional imaging in Crohn disease. Radiographics 2004; 24: 689-702
34. Maccioni F, Bruni A, Viscido A, Colaiacomo MC, Cocco A, Montesani C, Caprilli R, Marini M. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2006; 238; 517-530
35. Florie J, Wasser MN, Arts-Cieslik K, Akkerman EM, Siersema PD, Stoker J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. AJR Am J Roentgenol 2006; 186; 1384-1392
36. Zhang J, Israel GM, Hecht EM, Krinsky GA, Babb JS, Lee VS. Isotropic 3D T2-weighted MR cholangiopancreatography with parallel imaging: feasibility study. AJR Am J Roentgenol 2006; 187: 1564-1570
37. Lomas DJ. Techniques for magnetic resonance imaging of the bowel. Top Magn Reson Imaging 2002; 13: 379-387
38. Holzknecht N, Helmberger T, Herrmann K, Ochsenkuhn T, Goke B, Reiser M. [MRI in Crohn's disease after transduodenal contrast administration using negative oral MRI contrast media] Radiologe 2003; 43: 43-50
39. Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, Prassopoulos P. MR enteroclysis: technical considerations and clinical applications. Eur Radiol 2002; 12: 2651-2658
40. Laghi A, Carbone I, Catalano C, Iannaccone R. Paolantonio P, Baeli I, Trenna S, Passariello R. Polyethylene glycol solution as an oral contrast agent for MR imaging of the small bowel. AJR Am J Roentgenol 2001; 177: 1333-1334
41. Rieber A, Wruk D, Potthast S, Nussle K, Reinshagen M, Adler G, Brambs HJ. Diagnostic imaging in Crohn's disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 2000; 15: 176-181
42. Schmidt S, Lepori D, Meuwly JY, Duvoisin B, Meuli R, Michetti P, Felley C. Schnyder P, van Melle G, Denys A. Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of "sign-by-sign" correlation. Eur Radiol 2003; 13:1303-1311
43. Thoeni RF, Could RG. Enteroclysis and small bowel series: comparison of radiation dose and examination time. Radiology 1991; 178: 659-662
44. Frokjaer JB, Larsen E, Steffensen E, Nielsen AH, Drewes AM. Magnetic resonance imaging of the small bowel in Grohn's disease. Scand J Gastroenterol 2005; 40: 832-842
45. Macari M, Megibow AJ, Balthazar EJ. A pattern approach to the abnormal small bowel: observations at MDCT and CT enterography. AJR Am J Roentgenol 2007; 188: 1344-1355
46. Colombel JF, Solem CA, Sandborn WJ, Booya F, Loftus Ev Jr, Harmsen WS, Zinsmeister AR, Bodily KD, Fletcher JG. Quantitative measurement and visual assessment of ileal Crohn's disease activity by computed tomography enterography: correlation with endoscopic severity and C reactive protein. Gut 2006; 55: 1561-1567
47. Wiarda BM, Kuipers EJ, Houdijk LP, Tuynman HA. MR enteroclysis: imaging technique of choice in diagnosis of small bowel diseases. Dig Dis Sci 2005; 50: 1036-1040
48. Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Loftberg R, Modigliani R, Present DH, Rutgeerts P, Scholmerich J, Stange EF, Sutherland LR. A review of activity indices and efficacy endpoints for clinical trials of medical theraphy in adults with Crohn's disease. Gastroenterology 2002; 122: 512-530
49. Sempere GA, Martinez Sanjuan V, Medina Chulia E, Benages A, Tome Toyosato A, Canelles P, Bulto A, Quiles F, Puchades I, Cuquerella J, Celma J, Orti E. MRI evaluation of inflammatory activity in Chrohn's disease. AJR Am J Roentgenol 2005; 184:1829-1835
50. Fenoglio-Preiser CM, Noffsinger AE, Stemmermann GN, Lantz PE, Listrom MB, Rilke FO. Gastrointestinal Pathology. Philadelphia: Lippincott, 1999: 154
51. Trenkner SW, Halvorsen RA Jr, Thompson WM. Neoplasms of the upper gastrointestinal tract. Radiol Clin North Am 1994; 32: 15-24
52. Teplick SK, Glick SN, Keller MS. The duodenum. In: Putnam CE, Ravin CE, eds. Textbook of Diagnostic Imaging. Philadelphia: Saunders, 1988: 808-846
53. Rubesin SE, Gilchrist AM, Bronner M, Saul SH, Herlinger H, Grumbach K, Levine MS, Laufer I. Non-Hodgkin lymphoma of the small intestine. Radiographics 1990; 10: 985-998
54. Semelka RC, John G, Kelekis NL, Burdeny DA, Ascher SM. Small RC, John G, Kelekis NL, Burdeny DA, Ascher SM. Magn Reson Imaging 1996; 6: 855-860